AJP - Heart and Circulatory Physiology, Vol 257, Issue 4 1127-H1131, Copyright © 1989 by American Physiological Society

ARTICLES

Differential sensitivity to endothelin in canine arteries and veins

V. M. Miller, K. Komori, J. C. Burnett Jr and P. M. Vanhoutte
Department of Physiology and Biophysics, Mayo Graduate School of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905.

Experiments were designed to compare the sensitivity of venous and arterial smooth muscle to endothelin and to determine whether contractions to the peptide could be inhibited by endothelium-derived relaxing factor and nitric oxide. Rings of canine left anterior descending coronary, femoral, and mesenteric arteries and femoral and saphenous veins with and without endothelium were suspended for measurement of isometric force. In the presence of indomethacin, phentolamine, and propranolol, endothelin initiated concentration-dependent increases in tension in all rings. The veins were more sensitive to the peptide than were the arteries. Endothelin depolarized the smooth muscle of the saphenous veins and mesenteric arteries; the threshold concentration for depolarization was approximately 100 times lower in the veins (10(-10) M) than in the arteries (10(-8) M). Removal of the endothelium enhanced the sensitivity only of venous smooth muscle to endothelin. However, stimulation of the endothelium in the arteries with either acetylcholine or the calcium ionophore A23187 rapidly inhibited the maximal tension developed to the peptide. Nitric oxide inhibited contractions to endothelin in arteries and veins without endothelium; the inhibition was greater in the arteries than in the veins. These results indicate that venous smooth muscle is more sensitive than arterial smooth muscle to endothelin. In both blood vessels, endothelium-derived relaxing factor(s) can inhibit contractions to the peptide.

This article has been cited by other articles:

				J. Zhang, J. E. Lipa, C. E. Black, N. Huang, P. C. Neligan, F. T. K. Ling, R. H. Levine, J. L. Semple, and C. Y. Pang Pharmacological characterization of vasomotor activity of human musculocutaneous perforator artery and vein J Appl Physiol, December 1, 2000; 89(6): 2268 - 2275. [Abstract] [Full Text] [PDF]

				A. Ergul, K. Shoemaker, D. Puett, and R. L. Tackett Gender Differences in the Expression of Endothelin Receptors in Human Saphenous Veins In Vitro J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 511 - 517. [Abstract] [Full Text]

				V. Richard, M. Hogie, M. Clozel, B.-M. Loffler, and C. Thuillez In Vivo Evidence of an Endothelin-Induced Vasopressor Tone After Inhibition of Nitric Oxide Synthesis in Rats Circulation, February 1, 1995; 91(3): 771 - 775. [Abstract] [Full Text]

				Z.-G. Zhu, M.-S. Wang, Z.-B. Jiang, Z. Jiang, S.-X. Xu, C.-Y. Ren, and M.-X. Shi The dynamic change of plasma endothelin-1 during the perioperative period in patients with rheumatic valvular disease and secondary pulmonary hypertension J. Thorac. Cardiovasc. Surg., November 1, 1994; 108(5): 960 - 968. [Abstract] [Full Text]

				J. J. Khatri, K. M. Joyce, F. V. Brozovich, and S. A. Fisher Role of Myosin Phosphatase Isoforms in cGMP-mediated Smooth Muscle Relaxation J. Biol. Chem., September 28, 2001; 276(40): 37250 - 37257. [Abstract] [Full Text] [PDF]